Twitter

Novartis Announces CEO Joseph Jimenez to Retire in 2018

Joseph Jimenez, Chief Executive Officer (CEO) of Novartis, has informed the Board of Directors of his desire to step down as CEO in 2018, after eight years in position. The Board of Directors has appointed Vasant (Vas) Narasimhan, M.D., Global Head of Drug Development and Chief Medical Officer, as CEO of Novartis, effective February 1, 2018. Dr. Narasimhan is a member of the Executive Committee and joined Novartis in 2005.


Joseph Jimenez

Mr. Jimenez, who has been CEO since 2010, joined the company in 2007. He first led the Consumer Health Division, and then held the position of Division Head, Novartis Pharmaceuticals. Mr. Jimenez will step down as CEO, effective January 31, 2018, and will be available for advice and support at the request of the Chairman of the Board of Directors or the CEO until he retires from Novartis on August 31, 2018.

Joerg Reinhardt, Chairman of the Novartis Board of Directors, commented, “I would like to express my sincere appreciation for Joe’s achievements as CEO. During his tenure, Joe focused Novartis on leading global businesses, while divesting non-core divisions. Under his leadership the innovation pipeline was rejuvenated, and we successfully navigated the patent expirations of our two largest products. We anticipate a smooth transition as Joe built a strong leadership team and mentored his successor. Novartis will be well positioned to continue its momentum.”

Mr. Jimenez said, “Both from a professional and a personal perspective, this is the right moment to hand the leadership reins of the company to Vas. Our strong pipeline and the strategic moves we have taken to focus the company have put Novartis on a strong path for the future. On the personal side, after 10 wonderful years in Switzerland, my family is ready to return to Silicon Valley and the US. I’m confident that Vas will be an excellent successor.”

Dr. Vas Narasimhan

Dr. Narasimhan has held numerous leadership positions across Novartis in commercial, drug development and strategy roles. Prior to his current role he served as Head of Development for Novartis Pharmaceuticals. Before joining Novartis in 2005, he worked at McKinsey & Company.

He received his medical degree from Harvard Medical School in the US and obtained a master’s degree in public policy from Harvard’s John F. Kennedy School of Government. In addition, he holds a bachelor’s degree in biological sciences from the University of Chicago, also in the US. During and after his medical studies, he worked extensively on a range of health issues in developing countries. Dr. Narasimhan is an elected member of the US National Academy of Medicine. He is a US citizen born in 1976, married with 2 children, and lives in Basel, Switzerland.

Mr. Reinhardt added, “The strength of Novartis is our ability to drive science-based innovation. Vas is deeply anchored in medical science, has significant experience in managing the interfaces between Research and Development and commercial units and has strong business acumen with a track record of outstanding achievements. As a physician, he has a strong patient focus and a genuine humane perspective and care for the mission and values of Novartis. As a result, the Board of Directors is confident that Vas is the right choice to lead Novartis on our expected next growth phase, driving innovation and further strengthening our competitive position.”

Dr. Narasimhan said, “I would like to congratulate Joe and express my gratitude to Joe, Joerg, and the Board of Directors. I feel honored and humbled to be asked to lead Novartis. We will continue our legacy of bringing leading innovation to patients around the world. With our recent launches, our strong pipeline, broad capabilities, world-class leadership team, and committed people, I am very confident about our future.”

Latest News

Georgia Power, Georgia Power Foundation Invested More Than $20 Million To Help Meet Community Challenges in 2020

Originally published at southerncompany.com. Southern Company ranked No. 20 on The DiversityInc Top 50 Companies for Diversity list in 2021.   Georgia Power and the Georgia Power Foundation today released their annual Citizenship Report highlighting how the company, its employees and retirees gave back to Georgia communities last year, helping to build…

Toyota Financial Services Issues New Asset-Backed Green Bond, Highlighting Toyota’s Ongoing Commitment to Sustainability

Originally published at pressroom.toyota.com. Toyota Motor North America ranked No. 7 on The DiversityInc Top 50 Companies for Diversity list in 2021.   Toyota Financial Services (TFS) issued its latest Asset-Backed Green Bond, reinforcing the company’s longstanding commitment to the sale of environmentally friendly vehicles. Net proceeds from the $1.6…

ADP Recognized as a Customers’ Choice in 2021 Gartner Peer Insights ‘Voice of the Customer’

Originally published at mediacenter.adp.com. ADP ranked No. 8 on The DiversityInc Top 50 Companies for Diversity list in 2021.   Industry analyst firm Gartner recognized ADP as a Customers’ Choice with category distinctions in Midsize Enterprises and North America in its 2021 Gartner Peer Insights ‘Voice of the Customer’: Cloud HCM Suites…

Cigna building

Cigna and New York Life Expand Eligibility for ‘Brave of Heart Fund’ Grants Supporting Families of Healthcare Workers Who Lost Their Lives in the Fight Against COVID-19

Originally published at cigna.com. Cigna ranked No. 33 on The DiversityInc Top 50 Companies for Diversity list in 2021.   On June 17, the foundations of New York Life and Cigna announced that the Brave of Heart Fund, which provides monetary grants to the families of heroic health care workers…

Cox Auto Study on Dealerships Thriving in Digital

Originally published at coxenterprises.com. Cox Communications ranked No. 32 on The DiversityInc Top 50 Companies for Diversity list in 2021.   Cox Automotive has released a new study — “How to Thrive: ​Best Practices for an Accelerated Digital Landscape” — examining effective strategies dealerships are adopting to find profits and thrive…

Hershey Named To The Civic 50 And Recognized As Consumer Staples Leader For Commitment To Empowering Communities

Originally published at thehersheycompany.com. The Hershey Company ranked No. 10 on The DiversityInc Top 50 Companies for Diversity list in 2021.   The Hershey Company has been named a 2021 honoree of The Civic 50 by Points of Light, the world’s largest organization dedicated to volunteer service. In addition to being recognized…